To get ready for earnings season, focus on stocks in or near a potential buy zone ahead of their next quarterly report. IBD 50 and Sector Leaders member Align Technology ( ALGN ) currently fits that bill. It's expected to release its latest numbers around Jan. 30.
It's trading about 3% above a 266.51 buy point from a third-stage cup without handle .
[ibd-display-video id=2360792 width=50 float=left autostart=true] Keep in mind that buying close to when a stock reports can be risky. You don't know how the stock will report and how the market will react, and you don't have enough time to build a profit cushion. You can reduce your exposure by waiting to see how the company reports and how the market reacts.
In terms of top and bottom line numbers, the company has posted rising EPS growth over the last three quarters. Revenue gains have also moved higher over the same time frame.
Analysts expect earnings-per-share growth of 62% for the quarter, and 58% growth for the full year. Annual EPS estimates were recently revised upward.
The company has a 99 Composite Rating and holds the No. 1 rank among its peers in the Medical-Products industry group. Abiomed ( ABMD ) and Inogen ( INGN ) are also among the group's highest-rated stocks.
Note: Dates for earnings reports are subject to change. Check the company's website for any updates.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.